Journey of Resilience
Managing Stage IV colon cancer: Overcoming Treatment Challenges & Toxicity
How One Patient Overcame Liver Metastases Through Dendritic Cell Vaccine Therapy
A 59-year-old woman with advanced colon cancer and liver metastases defied the odds by achieving complete remission. Initially deemed inoperable, she underwent a combination of XELOX (CAPEOX) chemotherapy and personalized immunotherapy using dendritic cell vaccines. Remarkably, a follow-up colonoscopy a year later revealed no trace of her original tumor, and subsequent pathology confirmed her complete remission—a truly rare outcome.
Her treatment also dramatically boosted her immune system’s cancer-fighting cells. Over a four-month period, she received seven rounds of the vaccine, with only mild side effects reported.
Her journey demonstrates the promise of integrating conventional chemotherapy with cutting-edge immunotherapy, offering hope to patients facing advanced colon cancer.
Diagnosis
Stage IV colon cancer with multiple liver metastases
Biomarker profile: Not reported
Treatment
CAPEOX and Precision Immunotherapy (Dendritic Cell Vaccine, 7 doses / 4 months)
Outcome
Complete disappearance of the primary colon cancer and liver metastases confirmed by colonoscopy and pathology
Source: Japan Precision Clinic
